2m 2m 2m 2m 2m 2m 2m
INSPIREMD (NSPR)
NASDAQ
$0.98-$0.03 (-2.87%)
Price as of Jun 03, 2026 5:40 PM EDT- $43.1MMarket Cap
- -60.39%1-Year Change
- Medical DevicesIndustry
INSPIREMD (NSPR)
$0.98-$0.03 (-2.87%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 7.0M +12.96% | 6.2M +20.00% | 5.2M +15.04% | |
Cost of Revenue | 6.3M +15.03% | 5.5M +25.13% | 4.4M +8.49% | 4.1M +8.37% | |
Gross Profit | 2.6M +75.90% | 1.5M -16.66% | 1.8M +61.77% | 1.1M +48.14% | |
Sales and Marketing Expense | 16.6M +172.75% | 6.1M +57.02% | 3.9M +5.49% | 3.7M +26.04% | |
Research and Development Expense | -15.0M +10.04% | -13.6M +70.83% | -8.0M +2.19% | -7.8M +51.42% | |
Depreciation and Amortization Expense | 476,000 +70.00% | 280,000 +20.69% | 232,000 +23.40% | 188,000 +16.77% | |
Total Operating Expenses | 52.3M +49.28% | 35.0M +52.54% | 22.9M +15.73% | 19.8M +28.18% | |
Operating Profit | -49.6M +48.09% | -33.5M +58.46% | -21.1M +12.99% | -18.7M +27.16% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 891,000 -42.77% | 1.6M +20.51% | 1.3M +416.80% | 250,000 +259.24% | |
Income before Taxes | -48.7M +52.52% | -31.9M +60.93% | -19.9M +7.52% | -18.5M +24.14% | |
Income Taxes | 63,000 +6.78% | 59,000 -9.23% | 65,000 +132.14% | 28,000 -37.78% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -48.8M +52.43% | -32.0M +60.70% | -19.9M +7.71% | -18.5M +23.95% | |
Net Income from Continuing Operations Applicable to Common | -48.7M +52.52% | -31.9M +60.93% | -19.9M +7.52% | -18.5M +24.14% | |
Basic EPS and Net Income | -0.76 0.00% | -0.76 -7.32% | -0.82 -65.11% | -2.35 +15.76% | |
Diluted EPS and Net Income | -0.76 0.00% | -0.76 -7.32% | -0.82 -65.11% | -2.35 +15.76% | |
Basic Weighted Average Shares | 64.3M +53.42% | 41.9M +72.77% | 24.3M +208.29% | 7.9M +7.16% | |
Diluted Weighted Average Shares | 64.3M +53.42% | 41.9M +72.77% | 24.3M +208.29% | 7.9M +7.16% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.9M -52.74% | 18.9M +96.22% | 9.6M +108.12% | 4.6M -61.41% | |
Short-Term Investments | 45.3M +187.97% | 15.7M -46.50% | 29.4M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 54.2M +56.51% | 34.6M -11.24% | 39.0M +742.47% | 4.6M -61.41% | |
Total Current Assets | 61.5M +51.70% | 40.5M -8.24% | 44.2M +107.07% | 21.3M -42.51% | |
Accumulated Depreciation | 2.7M +17.46% | 2.3M +13.73% | 2.0M +6.92% | 1.9M +10.42% | |
Property and Plant and Equipment and Net | 3.6M +51.16% | 2.4M +123.68% | 1.1M +15.59% | 917,000 +45.09% | |
Total Long-Term Assets | 7.9M +26.20% | 6.3M +80.42% | 3.5M +4.72% | 3.3M +27.08% | |
Total Assets | 69.4M +48.28% | 46.8M -1.75% | 47.6M +93.25% | 24.7M -37.92% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 10.7M +39.52% | 7.7M +27.54% | 6.0M +18.74% | 5.1M +16.63% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 3.5M +14.72% | 3.0M +43.40% | 2.1M -3.11% | 2.2M +19.48% | |
Total Liabilities | 14.2M +32.48% | 10.7M +31.68% | 8.1M +12.15% | 7.3M +17.48% | |
Retained Earnings | -302.3M +19.24% | -253.5M +14.45% | -221.5M +9.88% | -201.6M +10.10% | |
Total Stockholders Equity | N/A N/A | 36.1M -8.65% | 39.5M +127.11% | 17.4M -48.13% | |
Total Shares Outstanding | 43.5M +63.59% | 26.6M +21.84% | 21.8M +162.17% | 8.3M +0.42% | |
Cash Flow | |||||
Cash from Operating Activities | -35.1M +60.52% | -21.9M +33.54% | -16.4M +5.37% | -15.5M +17.65% | |
Capital Expenditures | 1.7M +18.54% | 1.4M +267.98% | 381,000 -19.45% | 473,000 +37.50% | |
Cash from Investing Activities | -30.6M -341.75% | 12.6M +178.55% | -16.1M -290.64% | 8.4M +137.59% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 55.6M +201.15% | 18.5M -50.84% | 37.5M +26,910.00% | -140,000 -100.40% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 21.49% -26.22% | 29.12% +34.82% | 21.60% +28.78% | |
Operating Margin | N/A N/A | -478.00% +40.28% | -340.74% -5.84% | -361.88% +10.54% | |
Return on Assets | -83.96% +23.89% | -67.77% +23.01% | -55.10% -4.11% | -57.46% +10.71% | |
Return on Equity | N/A N/A | -84.68% +20.96% | -70.01% -3.59% | -72.62% +11.22% | |
Revenue Growth | N/A N/A | 12.96% -35.20% | 20.00% +32.96% | 15.04% -81.41% | |
Current Ratio | 5.74 +8.74% | 5.28 -28.05% | 7.34 +74.39% | 4.21 -50.71% | |
Cash Ratio | 0.83 -66.13% | 2.46 +53.86% | 1.60 +75.27% | 0.91 -66.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow